Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Trimetazidine, an anti-ischemic (anti-anginal) metabolic agent, could improve myocardial glucose utilization through inhibition of long-chain 3-ketoacyl CoA thiolase activity and results in a reduction in fatty acid oxidation and a stimulation of glucose oxidation.
説明 | Trimetazidine, an anti-ischemic (anti-anginal) metabolic agent, could improve myocardial glucose utilization through inhibition of long-chain 3-ketoacyl CoA thiolase activity and results in a reduction in fatty acid oxidation and a stimulation of glucose oxidation. |
ターゲット&IC50 | HADHA:3-hydroxyacyl-CoA dehydrogenase , Long chain 3-ketoyl coenzyme A thiolase:75 nM (IC50) |
分子量 | 266.3361 |
分子式 | C14H22N2O3 |
CAS No. | 5011-34-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Trimetazidine 5011-34-7 Others Inhibitor inhibitor inhibit